<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02449083</url>
  </required_header>
  <id_info>
    <org_study_id>13-007</org_study_id>
    <nct_id>NCT02449083</nct_id>
  </id_info>
  <brief_title>Magnet Resonance Imaging to Evaluate of Dynamic T2 Preparation Puls by Patients With Shunt or Chronic Obstructive Pulmonary Disease</brief_title>
  <official_title>Cardiac Magnet Resonance Imaging to Evaluate of Dynamic T2 Preparation Puls by Patient With Shunt or Patients With Chronic Obstructive Pulmonary Disease (COPD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is preliminary evidence that a dynamic T2 Preparations Puls sequence by cardiac magnet
      resonance imaging can differentiate between oxygenated and deoxygenated blood.

      In adult patients with inborn heart defects this has not yet been researched.
      Therefore,patients with ventriculoperitoneal shunt, septal and atrio-septal shunt should be
      examined. Also, patients with chronic obstructive pulmonary disease should be examined.

      The aim of this study is the validation of a novel magnet resonance sequence in terms of a
      distinction of oxygenated blood to deoxygenated blood in comparison to invasive method of
      measuring cardiac catheterization.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ventricular volumetry</measure>
    <time_frame>baseline</time_frame>
    <description>ventricular volumetry by Cardiac Magnet Resonance Imaging using dynamic T2 Preparation Puls for arithmetical determination of end-systolic volume, end-diastolic volume, ejection fraction, stroke volume and myocardial weight</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>oxygen partial pressure</measure>
    <time_frame>baseline</time_frame>
    <description>Determination of oxygen partial pressure (pO2) during angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>carbon dioxide partial pressure</measure>
    <time_frame>baseline</time_frame>
    <description>Determination of carbon dioxide partial pressure (pCO2) during angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pH-value</measure>
    <time_frame>baseline</time_frame>
    <description>Determination of pH-value od blood during angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gas analysis</measure>
    <time_frame>baseline</time_frame>
    <description>Determination of base excess of blood during angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gas analysis</measure>
    <time_frame>baseline</time_frame>
    <description>Determination of oxygen partial pressure (pO2), carbon dioxide partial pressure (pCO2), pH-value, base excess</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>12 month after procedure</time_frame>
    <description>Major adverse cardiac events: death, new indication for angiography, hospitalization</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Dynamic T2 Preparation</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <description>Patients with indication for MRI and coronary angiography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <description>Patients with atrioseptal or ventriculoseptal Shunt with indication to coronary angiography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3</arm_group_label>
    <description>Patients with chronic obstructive pulmonary disease with indication to coronary angiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI</description>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_label>Arm 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>coronary angiography</intervention_name>
    <description>coronary angiography</description>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_label>Arm 3</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with atrial septal defect (ASD) or ventricular septal defect (VSD) and COPD, who
        is planned for MRI and angiography
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with atrial septal defect (ASD) or ventricular septal defect (VSD) and COPD

          -  written informed consent

        Exclusion Criteria:

          -  patients with ST-elevation

          -  contraindication for MRI

          -  heavy kidney disease

          -  pregnant or breast feeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Britta Butzbach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heinrich-Heine University, Duesseldorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2015</study_first_submitted>
  <study_first_submitted_qc>May 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2015</study_first_posted>
  <last_update_submitted>November 19, 2015</last_update_submitted>
  <last_update_submitted_qc>November 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik f√ºr Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Dr. med. Britta Butzbach</investigator_title>
  </responsible_party>
  <keyword>MRI</keyword>
  <keyword>Shunt</keyword>
  <keyword>COPD</keyword>
  <keyword>Dynamic T2 Preparation Puls</keyword>
  <keyword>new sequences</keyword>
  <keyword>magnet resonance imaging</keyword>
  <keyword>ventricular septal defect</keyword>
  <keyword>Atrial septal defect</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

